Related Experiment Video
Updated: Aug 24, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Novel ABCC6 mutations in pseudoxanthoma elasticum
Nicolas Chassaing1, Ludovic Martin, Juliette Mazereeuw
1Department of Medical Genetics, Purpan Hospital, Toulouse, France.
Insights
Genetic analysis of Pseudoxanthoma elasticum (PXE) families identified novel ABCC6 mutations and recurrent mutation sites. The study highlights PXE
Area of Science:
- Genetics
- Molecular Biology
- Dermatology
Background:
- Pseudoxanthoma elasticum (PXE) is a rare genetic disorder affecting connective tissues.
- It is caused by mutations in the ABCC6 gene, leading to characteristic skin, eye, and cardiovascular symptoms.
- Understanding ABCC6 mutations is crucial for diagnosing and managing PXE.
Purpose of the Study:
- To identify and characterize ABCC6 gene mutations in a cohort of families with PXE.
- To investigate genotype-phenotype correlations and inheritance patterns in PXE.
- To expand the mutation database for ABCC6 and aid genetic counseling.
Main Methods:
- Genetic analysis of 19 families with a clinical diagnosis of PXE.
- Mutation screening of the ABCC6 gene.
- Analysis of mutation frequencies, recurrence, and genotype-phenotype relationships.
Main Results:
- Identified 16 distinct ABCC6 mutations, including nine novel variants, with a mutation detection rate of 77%.
- Arginine codon 518 was a recurrently mutated site (R518Q and R518X).
- No clear genotype-phenotype correlation was observed, with significant intra-familial variability and evidence supporting recessive inheritance.
Conclusions:
- The study contributes to the growing knowledge of ABCC6 mutations in PXE.
- Phenotypic variability and inheritance patterns in PXE are complex.
- Findings are valuable for genetic counseling and further research into PXE pathogenesis.
Abstract:
Pseudoxanthoma elasticum (PXE) is a heritable connective tissue disorder caused by mutations in an ABC (ATP-Binding Cassette) transporter gene (ABCC6), which manifests with cutaneous, ophthalmologic, and cardiovascular findings. We studied a cohort of 19 families with PXE, and identified 16 different mutations, nine of which were novel variants. The mutation detection rate was about 77%. We found that arginine codon 518 was, with the previously described R1141X and EX23_29del, a recurrently mutated amino acid (11.5% of the mutations detected for each variant R518Q and R518X). No clear delineation of genotype/phenotype correlation was identified, and marked intra-familial variability of the disease was seen in one family. One family with pseudodominant inheritance displayed three distinct ABCC6 mutations, providing further evidence for the probable exclusive recessive transmission of PXE. These data contribute to the expanding database of ABCC6 mutations, to the description of phenotypic variability, and inheritance in PXE, and should be helpful for genetic counselling.
Related Concept Videos
Abnormal Proliferation
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
